Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
recent articles
Lunsumio® (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma Application is based on results from the pivotal phase I/II study...
What we do At the end of the day, what we do is straightforward: Pathomation makes middleware software for digital pathology. Now depending on who you talk to, one or more terms in that statement may take some explaining: Pathomation:...
The Northern Care Alliance NHS Foundation Trust will be deploying a new laboratory information system for its pathology services to improve clinical practice and patient care. Northern Care Alliance NHS Foundation Trust was formed last...
HCG: This collaboration is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold. Further, this solution will enable pathologists to collaborate seamlessly across geographies...
CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that it has secured $4 million in seed funding led by...
Siemens Healthineers and The Ohio State University Wexner Medical Center announce strategic partnership Ohio State Wexner Medical Center and Siemens Healthineers have committed to a new strategic relationship to bring the most advanced...
